Following its October management board meeting, the European Medicines Agency (EMA) has presented results and achievements of ...
The Graves’ orbitopathy treatment market was worth $2.1 billion in 2024 across leading regions, with the USA accounting for ...
Ireland-based Jazz Pharmaceuticals has announced the US Food and Drug Administration (FDA) approval of Zepzelca ...
US late-stage biotech Rocket Pharmaceuticals today announced via a Securities Exchange filing that it has voluntarily ...
San Diego, USA-based biotech Cidara Therapeutics yesterday revealed it has received an award valued up to $339 million from ...
US biotech Cirrus Therapeutics has emerged from stealth with $11 million in seed financing to advance a gene therapy for dry ...
US biotech Amgen (Nasdaq: AMGN) has reported that its cholesterol therapy Repatha (evolocumab) hit both primary endpoints in ...
India’s pharmaceutical industry has long been cast as the world’s pharmacy, churning out affordable generics and APIs at ...
Following regulatory approval earlier this year, South Korean firm Celltrion’ Avtozma (tocilizumab-anoh) intravenous (IV) ...
US clinical-stage biotech OncoC4 revealed it has closed a Series B financing round of nearly $50 million, led by GBA Fund, ...
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) to NPI-001 (N-acetylcysteine amide) tablets, Texas, USA-based clinical-stage biotech Nacuity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback